Back
Mereo BioPharma Group PLC Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
MREO
Mereo BioPharma Group PLC
Last Price:
3.68
Seasonality Move:
12.89%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Mereo BioPharma Group PLC Price Quote
$3.68
Mereo BioPharma Group PLC Key Stats
Sell
45
Mereo BioPharma Group PLC (MREO)
is a Sell
Day range:
$3.45 - $3.69
52-week range:
$1.86 - $5.02
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
7.87%
Volume:
723.6K
Avg. volume:
717.2K
1-year change:
61.4%
Market cap:
$570.9M
Revenue:
$10M
EPS:
$-0.3
How Much Does Mereo BioPharma Group PLC Make?
Data Unavailable
Is Mereo BioPharma Group PLC Growing As A Company?
Data Unavailable
Mereo BioPharma Group PLC Stock Price Performance
-
Did Mereo BioPharma Group PLC Stock Go Up Last Month?
Mereo BioPharma Group PLC share price went down by -18.76% last month -
Did MREO's Share Price Rise Over The Last Year?
MREO share price rose by 61.4% over the past 1 year
What Is Mereo BioPharma Group PLC 52-Week High & Low?
-
What Is Mereo BioPharma Group PLC’s 52-Week High Share Price?
Mereo BioPharma Group PLC has traded as high as $5.02 over the past 52 weeks -
What Is Mereo BioPharma Group PLC’s 52-Week Low Share Price?
Mereo BioPharma Group PLC has traded as low as $1.86 over the past 52 weeks
Mereo BioPharma Group PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mereo BioPharma Group PLC?
-
How Much Debt Does Mereo BioPharma Group PLC Have?
Total long term debt quarterly is $0 -
How Much Cash Does Mereo BioPharma Group PLC Have?
Cash and short term investments quarterly total is $80.5M -
What Is Mereo BioPharma Group PLC’s Book Value Per Share?
Book value per share is 0.47
Is Mereo BioPharma Group PLC Cash Flow Positive?
-
What Is MREO Cash Flow From Operations?
Cash flow from operations (TTM) is -$30.2M -
What Is Mereo BioPharma Group PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Mereo BioPharma Group PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$699K
Mereo BioPharma Group PLC Return On Invested Capital
Data Unavailable
Mereo BioPharma Group PLC Earnings Date & Stock Price
-
What Is Mereo BioPharma Group PLC's Stock Price Today?
A single share of MREO can be purchased today for 3.68 -
What Is Mereo BioPharma Group PLC’s Stock Symbol?
Mereo BioPharma Group PLC trades on the nasdaq under the ticker symbol: MREO -
When Is Mereo BioPharma Group PLC’s Next Earnings Date?
The next quarterly earnings date for Mereo BioPharma Group PLC is scheduled on March 27, 2025 -
When Is MREO's next ex-dividend date?
Mereo BioPharma Group PLC's next ex-dividend date is November 22, 2024 -
How To Buy Mereo BioPharma Group PLC Stock?
You can buy Mereo BioPharma Group PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mereo BioPharma Group PLC Competitors
-
Who Are Mereo BioPharma Group PLC's Competitors?
Below is a list of companies who compete with Mereo BioPharma Group PLC or are related in some way:
Mereo BioPharma Group PLC Dividend Yield
-
What Is MREO Dividend Yield?
Mereo BioPharma Group PLC’s dividend yield currently is 0% -
What Is Mereo BioPharma Group PLC’s Payout Ratio?
Mereo BioPharma Group PLC’s payout ratio is 0% -
When Did Mereo BioPharma Group PLC Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Mereo BioPharma Group PLC’s Dividend Per Share?
Mereo BioPharma Group PLC pays a dividend of $0.00 per share
Mereo BioPharma Group PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -11.9% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 7.18 |
| Upside from Last Price: | 95.2% |